A practical approach to the autoimmune disease-related interstitial lung disease
Article Sidebar
Main Article Content
Abstract
Autoimmune diseases are heterogeneous groups of immune-mediated inflammatory diseases. However, they have multi-organ involvement, and patterns of organ complication usually present as the phenotypic trademark for each disease caused by different antibodies that recognize different sets of antigens. Pulmonary parenchyma is sometimes a target and complicated as interstitial lung disease. Autoimmune disease-related interstitial lung disease could occur at acute onset and progress rapidly or at chronic onset and insidiously progress. Host characteristics, clinical features suggesting autoimmune diseases, and serological tests help delineate the cause of ILD in the differential diagnosis.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
(ใส่ข้อความเดียวกันกับ ก๊อปปี้ไลน์ก็ได้)ดูตัวอย่างได้ที่หน้าบทความ---บทความนี้ตีพิมพ์เป็นลิขสิทธื์ของใคร...
References
Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. Lancet. 2022;400(10354):769-786.
Shah Gupta R, Koteci A, Morgan A, George PM, Quint JK. Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review. BMJ Open Respir Res. 2023;10(1):e001291.
Didier K, Bolko L, Giusti D, Toquet S, Robbins A, Antonicelli F, et al. Autoantibodies Associated with Connective Tissue Diseases: What Meaning for Clinicians? Front Immunol. 2018;9:541.
Pepmueller PH. Undifferentiated Connective Tissue Disease, Mixed Connective Tissue Disease, and Overlap Syndromes in Rheumatology. Mo Med. 2016;113:136-40.
Jennette, J, Falk R, Bacon P, Basu N, Cid M, Ferrario F, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013; 65: 1–11.
Bergamasco A, Hartmann N, Wallace L, Verpillat P. Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clin Epidemiol. 2019;11:257-273.
Foocharoen C, Peansukwech U, Mahakkanukrauh A, Suwannaroj S, Pongkulkiat P, Khamphiw P, et al. Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study. Int J Rheum Dis. 2020; 23:945–957.
Hoffmann-Vold AM, Aaløkken TM, Lund MB, Garen T, Midtvedt Ø, Brunborg C, et al. Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis. Arthritis Rheumatol. 2015;67:2205-12.
Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685-1699.
Decker P, Sobanski V, Moulinet T, Launay D, Hachulla E, Valentin V, et al. Interstitial pneumonia with autoimmune features: Evaluation of connective tissue disease incidence during follow-up. Eur J Intern Med. 2022;97:62-68.
Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, et al. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J. 2020;55(5):1902026.
Matucci-Cerinic M, Allanore Y, Czirják L, Tyndall A, Müller-Ladner U, Denton C, et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research Group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis. 2009;68(9):1377-80.
Minier T, Guiducci S, Bellando-Randone S, Bruni C, Lepri G, Czirják L, et al. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Ann Rheum Dis. 2014;73(12):2087-93.
Senécal JL, Raynauld JP, Troyanov Y. Editorial: A New Classification of Adult Autoimmune Myositis. Arthritis Rheumatol. 2017;69(5):878-884.
Izuka S, Komai T, Shoda H, Fujio K. Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathy. Rheumatol Int. 2023;43(2):335-343.
Sun KY, Fan Y, Wang YX, Zhong YJ, Wang GF. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020. Semin Arthritis Rheum. 2021;51(1):175-191.
Galindo-Feria AS, Notarnicola A, Lundberg IE, Horuluoglu B. Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond. Front Immunol. 2022;13:866087.
Nombel A, Fabien N, Coutant F. Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies. Front Immunol. 2021;12:773352.
Wang H, Lv J, He J, Wu W, Zhong Y, Cao S, et al. The prevalence and effects of treatments of rapidly progressive interstitial lung disease of dermatomyositis/polymyositis adults: A systematic review and meta-analysis. Autoimmun Rev. 2023;22(8):103335.
Xie H, Zhang D, Wang Y, Shi Y, Yuan Y, Wang L, et al. Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: A meta-analysis and systematic review. Semin Arthritis Rheum. 2023;62:152231.
Fazeli MS, Khaychuk V, Wittstock K, Han X, Crocket G, Lin M, et al. Rheumatoid arthritis-associated interstitial lung disease: epidemiology, risk/prognostic factors, and treatment landscape. Clin Exp Rheumatol. 2021;39(5):1108-1118.
Kadura S, Raghu G. Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management. Eur Respir Rev. 2021;30(160):210011.
Chung JH, Cox CW, Montner SM, Adegunsoye A, Oldham JM, Husain AN, et al. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis. AJR Am J Roentgenol. 2018;210(2):307-313.
Joy GM, Arbiv OA, Wong CK, Lok SD, Adderley NA, Dobosz KM, et al. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Eur Respir Rev. 2023;32(167):220210.
Lin W, Xin Z, Zhang J, Liu N, Ren X, Liu M, et al. Interstitial lung disease in Primary Sjögren's syndrome. BMC Pulm Med. 2022;22(1):73.
Lee CT, Strek ME. The other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus. Curr Opin Pulm Med. 2021;27(5):388-395.
La Rocca G, Ferro F, Sambataro G, Elefante E, Fonzetti S, Fulvio G, Navarro IC, Mosca M, Baldini C. Primary-Sjögren's-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies. J Clin Med. 2023;12(10):3428.
Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, et al. Interstitial lung disease in Sjögren's syndrome: a clinical review. Clin Exp Rheumatol. 2020;38 Suppl 126(4):291-300.
Silvério-António M, Martins-Martinho J, Melo AT, Guimarães F, Dourado E, Oliveira D, et al. Predictors of Interstitial Lung Disease in Mixed Connective Tissue Disease. J Clin Med. 2023;12(23):7481.
Boleto G, Reiseter S, Hoffmann-Vold AM, Mirouse A, Cacoub P, Matucci-Cerinic M, et al. The phenotype of mixed connective tissue disease patients having associated interstitial lung disease. Semin Arthritis Rheum. 2023;63:152258.
Kawano-Dourado L, Baldi BG, Kay FU, Dias OM, Gripp TE, Gomes PS, et al. Pulmonary involvement in long-term mixed connective tissue disease: functional trends and image findings after 10 years. Clin Exp Rheumatol. 2015;33(2):234-40.
Haye Salinas MJ, Caeiro F, Saurit V, Alvarellos A, Wojdyla D, Scherbarth HR, et al. Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin American inception cohort (GLADEL). Lupus. 2017;26(13):1368-1377.
Wang DY. Diagnosis and management of lupus pleuritis. Curr Opin Pulm Med. 2002;8(4):312-6.
Man BL, Mok CC. Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus. 2005;14(10):822-826.
Amarnani R, Yeoh SA, Denneny EK, Wincup C. Lupus and the Lungs: The Assessment and Management of Pulmonary Manifestations of Systemic Lupus Erythematosus. Front Med (Lausanne). 2021;7:610257.
Aguilera-Pickens G, Abud-Mendoza C. Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage. Reumatol Clin (Engl Ed). 2018;14(5):294-300.
Sebastiani M, Manfredi A, Vacchi C, Cassone G, Faverio P, Cavazza A, et al. Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis. Clin Exp Rheumatol. 2020;38 Suppl 124(2):221-231.
Kadura S, Raghu G. Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review. Eur Respir Rev. 2021;30(162):210123.
Alba MA, Flores-Suárez LF, Henderson AG, Xiao H, Hu P, Nachman PH, et al. Interstitial lung disease in ANCA vasculitis. Autoimmun Rev. 2017;16(7):722-729.